ÂÜÀòÂÒÂ×

Stephen Camiolo is currently the Vice President of Cell Therapy Account Teams at Iovance Biotherapeutics, Inc. Prior to this role, Stephen held various leadership positions at companies such as CRISPR Therapeutics, Kite Pharma, Gilead Sciences, and Novartis. With a background in nursing and extensive experience in market access, pricing, and marketing in the healthcare industry, Stephen has a proven track record of developing and executing successful commercial strategies for pharmaceutical products globally.